Cargando…

m6A reading protein RBMX as a biomarker for prognosis and tumor progression in esophageal cancer

BACKGROUND: As a member of m6A methylated binding protein, RNA binding motif protein X-linked (RBMX) has been reported to be associated with tumor invasion, metastasis and prognosis. However, the prognostic significance of RBMX expression in esophageal cancer (ESCA) remains unclear. METHODS: Based o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tuersun, Hainisayimu, Liu, Ling, Zhang, Jing, Maimaitizunong, Rezeye, Tang, Xiaohui, Li, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583014/ https://www.ncbi.nlm.nih.gov/pubmed/37859733 http://dx.doi.org/10.21037/tcr-23-84

Ejemplares similares

Ferroptosis and its emerging role in esophageal cancer
por: Maimaitizunong, Rezeye, et al.
Publicado: (2022)

Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy
por: Zhang, Jing, et al.
Publicado: (2022)

RBMX Protein Expression in T-Cell Lymphomas Predicts Chemotherapy Response and Prognosis
por: Schümann, Franziska Lea, et al.
Publicado: (2021)

RBMX involves in telomere stability maintenance by regulating TERRA expression
por: Liu, Jingfan, et al.
Publicado: (2023)

A nomogram model based on the number of examined lymph nodes–related signature to predict prognosis and guide clinical therapy in gastric cancer
por: Li, Huling, et al.
Publicado: (2022)

PUMILIO, but not RBMX, binding is required for regulation of genomic stability by noncoding RNA NORAD
por: Elguindy, Mahmoud M, et al.
Publicado: (2019)

RBMX suppresses tumorigenicity and progression of bladder cancer by interacting with the hnRNP A1 protein to regulate PKM alternative splicing
por: Yan, Qiuxia, et al.
Publicado: (2021)

Theileria annulata Subtelomere-Encoded Variable Secreted Protein-TA05575 Binds to Bovine RBMX2
por: Li, Zhi, et al.
Publicado: (2021)

Transcriptional control of CBX5 by the RNA binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia
por: Prieto, Camila, et al.
Publicado: (2021)

A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA damage response
por: Adamson, Britt, et al.
Publicado: (2012)

Alu element in the RNA binding motif protein, X-linked 2 (RBMX2) gene found to be linked to bipolar disorder
por: Laine, Pia, et al.
Publicado: (2021)

hnRNP G/RBMX enhances HPV16 E2 mRNA splicing through a novel splicing enhancer and inhibits production of spliced E7 oncogene mRNAs
por: Hao, Chengyu, et al.
Publicado: (2022)

Interleukin-8 and Interleukin-6 Are Biomarkers of Poor Prognosis in Esophageal Squamous Cell Carcinoma
por: Pastrez, Paula Roberta Aguiar, et al.
Publicado: (2023)

m6A-related lncRNAs are potential biomarkers for the prognosis of COAD patients
por: Xu, Chenyang, et al.
Publicado: (2022)

Biomarkers for Early Detection, Prognosis, and Therapeutics of Esophageal Cancers
por: Rai, Vikrant, et al.
Publicado: (2023)

Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer
por: Chen, Meilan, et al.
Publicado: (2013)

m6A demethylase FTO promotes tumor progression via regulation of lipid metabolism in esophageal cancer
por: Duan, Xiaoran, et al.
Publicado: (2022)

Study on the Compressive Strength of Alkali Activated Fly Ash and Slag under the Different Silicate Structure
por: Wang, Zhipu, et al.
Publicado: (2021)

Tryptophan Metabolites as Biomarkers for Esophageal Cancer Susceptibility, Metastasis, and Prognosis
por: Chen, Yun, et al.
Publicado: (2022)

USP9X expression correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma
por: Peng, Jing, et al.
Publicado: (2013)

Identification of m6A-Related Biomarkers Associated with Prognosis of Colorectal Cancer
por: Zhang, Zhiyong, et al.
Publicado: (2021)

Erratum to: - Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer
por: Chen, Meilan, et al.
Publicado: (2014)

MicroRNAs as biomarkers for the progression and prognosis of colon carcinoma
por: Zhang, Hui, et al.
Publicado: (2018)

Upregulation of Centromere Proteins as Potential Biomarkers for Esophageal Squamous Cell Carcinoma Diagnosis and Prognosis
por: Wang, Xiao, et al.
Publicado: (2022)

M(1)A and m(7)G modification-related genes are potential biomarkers for survival prognosis and for deciphering the tumor immune microenvironment in esophageal squamous cell carcinoma
por: Wang, Ruixi, et al.
Publicado: (2023)

m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer
por: Chen, Mei, et al.
Publicado: (2019)

Fructose-1,6-bisphosphatase 1 (FBP1) is an independent biomarker associated with a favorable prognosis in esophageal adenocarcinoma
por: Damanakis, Alexander, et al.
Publicado: (2022)

Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma
por: Yang, Yuchong, et al.
Publicado: (2019)

METTL3-mediated m(6)A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway
por: Han, Hui, et al.
Publicado: (2021)

Bioinformatic analysis of m6A “reader” YTH family in pan-cancer as a clinical prognosis biomarker
por: Li, Lin, et al.
Publicado: (2023)

The Role of m(6)A Modification and m(6)A Regulators in Esophageal Cancer
por: Li, Yuekao, et al.
Publicado: (2022)

m(6)A demethylase ALKBH5 suppression contributes to esophageal squamous cell carcinoma progression
por: Xiao, Dong, et al.
Publicado: (2021)

Ring box protein-1 is associated with a poor prognosis and tumor progression in esophageal cancer
por: Kunishige, Tomohiro, et al.
Publicado: (2020)

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Pan Pan, et al.
Publicado: (2022)

The prognosis biomarkers based on m6A-related lncRNAs for myeloid leukemia patients
por: Yang, Li-Rong, et al.
Publicado: (2022)

Comprehensive Analysis of Regulatory Networks of m6A Regulators and Reveals Prognosis Biomarkers in Sarcoma
por: Pang, Boran, et al.
Publicado: (2022)

The N6-Methyladenosine- (m6A-) Associated Genes Act as Strong Key Biomarkers for the Prognosis of Pancreatic Adenocarcinoma
por: Li, Fei, et al.
Publicado: (2021)

DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis
por: Ji, Yan-Mei, et al.
Publicado: (2016)

Downregulation of HuR Inhibits the Progression of Esophageal Cancer through Interleukin-18
por: Xu, Xiaohui, et al.
Publicado: (2018)

m(6)A Reader HNRNPA2B1 Promotes Esophageal Cancer Progression via Up-Regulation of ACLY and ACC1
por: Guo, Huimin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_te8ps0gv4ob95gqapm3jbkq2jt